MediWound Ltd. (MDWD)
Last updated: 2026-10-20 12:04:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
MediWound Ltd. (MDWD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $12.70, with a market capitalization of $152.99M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.84 to $20.03. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$152.99M | |
$11.94 | |
$135.17 | |
$7.10 | |
$11.85 | |
183.40K | |
85.76K | |
-- | |
$20.03 | |
$11.84 | |
-- | |
-- |
MediWound Ltd. (MDWD) Pre-Market Stock Price
MediWound Ltd. (MDWD) is trading at $12.41 in pre-market trading as of 2026-10-19 23:31:00, up 4.69% ($0.56) from the previous close of $11.85
Pre-market trading shows how investors are pricing MDWD before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
MediWound Ltd. (MDWD) 7-Day Stock Price Change
Over the past seven days, MediWound Ltd. (MDWD) moved from $12.54 to $12.70, representing a gain of 1.27% ($0.16).
The stock traded between $11.84 and $13.15 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 92.44 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
MDWD 52-Week Price Position
Position in Range: 10.5%
MDWD is currently trading at $12.70, placing it 10.5% of the way from its 52-week low of $11.84 to its 52-week high of $20.03. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is MediWound Ltd. (MDWD)?
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
MediWound Ltd. Information
| Employees | 121 |
| Exchange | NASDAQ |
| Company Website |
How to Buy MediWound Ltd. (MDWD) Stock on MEXC
Eligible investors can buy real shares of MediWound Ltd. (MDWD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is MediWound Ltd. (MDWD) stock price today?
2.Is MDWD stock going up or down today?
3.What is MDWD pre-market price?
4.What is MDWD after-hours price?
5.Is MDWD stock trading now?
6.Where does MDWD sit relative to its 52-week high and low?
7.What sector is MediWound Ltd. in?
8.What is MediWound Ltd.'s market capitalization and where is it listed?
9.How is MDWD valued in terms of P/E ratio and EPS?
10.Does MediWound Ltd. pay a dividend?
Explore More US Stocks
Search Stocks
MDWD Stock Calculator
Estimate the value between MDWD shares and USD.
MDWD Shares to USD
1.00 MDWD shares = 12.699 USD
Calculations are estimates based on the latest available price and are for reference only.


